Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Ramya Krishna Vadlapatla, Mitesh Patel, Durga K Paturi, Dhananjay Pal & Ashim K Mitra. (2014) Clinically relevant drug–drug interactions between antiretrovirals and antifungals. Expert Opinion on Drug Metabolism & Toxicology 10:4, pages 561-580.
Read now
Read now
Gopal Krishna, Angela Sansone-Parsons & Bhavna Kantesaria. (2007) Drug interaction assessment following concomitant administration of posaconazole and phenytoin in healthy men. Current Medical Research and Opinion 23:6, pages 1415-1422.
Read now
Read now
Qing Ma, Olanrewaju O Okusanya, Patrick F Smith, Robert DiCenzo, Judianne C Slish, Linda M Catanzaro, Alan Forrest & Gene D Morse. (2005) Pharmacokinetic drug interactions with non-nucleoside reverse transcriptase inhibitors. Expert Opinion on Drug Metabolism & Toxicology 1:3, pages 473-485.
Read now
Read now
Luis Ostrosky-Zeichner. (2004) Novel approaches to antifungal prophylaxis. Expert Opinion on Investigational Drugs 13:6, pages 665-672.
Read now
Read now
Harumi Yamada, Hajime Kotaki & Takashi Takahashi. (2003) Recommendations for the treatment of fungal pneumonias. Expert Opinion on Pharmacotherapy 4:8, pages 1241-1258.
Read now
Read now
Eleftherios Mylonakis, Frederick M Ausubel, Robin Jian Tang & Stephen B Calderwood. (2003) The art of serendipity: killing of Caenorhabditis elegans by human pathogens as a model of bacterial and fungal pathogenesis. Expert Review of Anti-infective Therapy 1:1, pages 167-173.
Read now
Read now
Articles from other publishers (26)
Alaa M. Alqahtani, Asmaa G. Safi El-Din, Randa Abdou, Ali H. Amin, Hany H. Arab & Ahmed H. Abdelazeem. (2022)
Novel S-Mercaptotriazolebenzothiazole-Based Derivatives as Antimicrobial
Agents: Design, Synthesis, and
In Vitro
Evaluation
. Letters in Drug Design & Discovery 19:10, pages 925-937.
Crossref
Crossref
Tawanny K. B. Aguiar, Nilton A. S. Neto, Cleverson D. T. Freitas, Ayrles F. B. Silva, Leandro P. Bezerra, Ellen A. Malveira, Levi A. C. Branco, Felipe P. Mesquita, Gustavo H. Goldman, Luciana M. R. Alencar, Jose T. A. Oliveira, Ralph Santos-Oliveira & Pedro F. N. Souza. (2022) Antifungal Potential of Synthetic Peptides against Cryptococcus neoformans: Mechanism of Action Studies Reveal Synthetic Peptides Induce Membrane–Pore Formation, DNA Degradation, and Apoptosis. Pharmaceutics 14:8, pages 1678.
Crossref
Crossref
Robert J. Tancer, Yina Wang, Siddhi Pawar, Chaoyang Xue & Gregory R. Wiedman. (2022)
Development of Antifungal Peptides against Cryptococcus neoformans; Leveraging Knowledge about the
cdc50Δ
Mutant Susceptibility for Lead Compound Development
. Microbiology Spectrum 10:2.
Crossref
Crossref
Dickson Pius Wande, Raphael Zozimus Sangeda, Prosper Tibalinda, Innocent Kairuki Mutta, Sonia Mkumbwa, Adonis Bitegeko & Eliangiringa Kaale. (2019) Pharmaceuticals imports in Tanzania: Overview of private sector market size, share, growth and projected trends to 2021. PLOS ONE 14:8, pages e0220701.
Crossref
Crossref
V. V. Belakhov, V. A. Kolodyaznaya & A. V. Garabadzhiu. (2014) Chemical modification of heptaene macrolide antibiotic Amphotericin B under conditions of the Atherton-Todd reaction. Russian Journal of General Chemistry 84:10, pages 1953-1961.
Crossref
Crossref
Te-Yu Lin, Min-Hui Yang & Feng-Yee Chang. (2013) A Randomized, Phase I, 3-way Crossover Study to Examine the Effects of Food on the Pharmacokinetics of Single Doses of 400 mg Posaconazole Oral Suspension in Healthy Male Taiwanese Subjects. Therapeutic Drug Monitoring 35:2, pages 223-227.
Crossref
Crossref
. (2012) Clinical Guidelines for the Treatment and Prevention of Opportunistic Infections in HIV-infected Koreans. Infection & Chemotherapy 44:3, pages 93.
Crossref
Crossref
Ireneusz Rzewnicki, Ewa Olszewska & Dorota Rogowska-Szadkowska. (2012) HIV infections in otolaryngology. Medical Science Monitor 18:3, pages RA17-RA21.
Crossref
Crossref
Martha Donoghue, Nita L. Seibel, Peter S. Francis & Thomas J. Walsh. 2009. Clinical Mycology. Clinical Mycology
561
589
.
Devendra K. Choudhary & Bhavdish N. Johri. 2009. Yeast Biotechnology: Diversity and Applications. Yeast Biotechnology: Diversity and Applications
19
46
.
Juan Carlos Montejo González, Mercedes Catalán González & Cristóbal León Gil. (2008) Utilidad clínica de la anidulafungina en el tratamiento de las candidiasis esofágicas, candidemias y candidiasis invasoras. Revista Iberoamericana de Micología 25:2, pages 107-118.
Crossref
Crossref
V. V. Belakhov & Yu. D. Shenin. (2007) Synthesis and antifungal activity of N-benzyl derivatives of amphotericin B. Pharmaceutical Chemistry Journal 41:7, pages 362-366.
Crossref
Crossref
Kishor M. Wasan, Olena Sivak, Michael Rosland, Verica Risovic & Karen Bartlett. (2007) Assessing the antifungal activity, pharmacokinetics, and tissue distribution of amphotericin B following the administration of Abelcet® and AmBisome® in combination with caspofungin to rats infected with Aspergillus fumigatus. Journal of Pharmaceutical Sciences 96:7, pages 1737-1747.
Crossref
Crossref
Jeffrey S. Stroup, Johnny R. Stephens, Damon L. Baker & Madhuri Lad. (2017) Amphotericin B Formulation Confusion and Mortality in an HIV-Seropositive Patient. Hospital Pharmacy 42:6, pages 532-536.
Crossref
Crossref
Deborah KB Runyoro, Mecky IN Matee, Olipa D Ngassapa, Cosam C Joseph & Zakaria H Mbwambo. (2006) Screening of Tanzanian medicinal plants for anti-Candida activity. BMC Complementary and Alternative Medicine 6:1.
Crossref
Crossref
R. Lugert, C. Schettler & U. Gross. (2006) Comparison of different protocols for DNA preparation and PCR for the detection of fungal pathogens in vitro. Mycoses 49:4, pages 298-304.
Crossref
Crossref
Kimberly Vinette Herrin, Abraham Miranda & David Loebenberg. (2005) Posaconazole therapy for systemic coccidioidomycosis in a chimpanzee (Pan troglodytes): a case report. Mycoses 48:6, pages 447-452.
Crossref
Crossref
M. Lohitnavy, O. Lohitnavy, O. Thangkeattiyanon & W. Srichai. (2005) Reduced oral itraconazole bioavailability by antacid suspension. Journal of Clinical Pharmacy and Therapeutics 30:3, pages 201-206.
Crossref
Crossref
Rama Falk, Moshe Hacham, Abraham Nyska, Julie F. Foley, Abraham J. Domb & Itzhack Polacheck. (2005) Induction of interleukin-1β, tumour necrosis factor-α and apoptosis in mouse organs by amphotericin B is neutralized by conjugation with arabinogalactan. Journal of Antimicrobial Chemotherapy 55:5, pages 713-720.
Crossref
Crossref
R. Courtney, A. Sansone, W. Smith, T. Marbury, P. Statkevich, M. Martinho, M. Laughlin & S. Swan. (2005) Posaconazole Pharmacokinetics, Safety, and Tolerability in Subjects With Varying Degrees of Chronic Renal Disease. The Journal of Clinical Pharmacology 45:2, pages 185-192.
Crossref
Crossref
J. Jones, B.R. Kosloff, E.N. Benveniste, G.M. Shaw & O. Kutsch. (2005) Amphotericin-B-mediated reactivation of latent HIV-1 infection. Virology 331:1, pages 106-116.
Crossref
Crossref
N. de Wet, A. L. Cuentas, J. Suleiman, E. Baraldi, E. F. Krantz, M. Della Negra & H. Diekmann-Berndt. (2004) A Randomized, Double-Blind, Parallel-Group, Dose-Response Study of Micafungin Compared with Fluconazole for the Treatment of Esophageal Candidiasis in HIV-Positive Patients. Clinical Infectious Diseases 39:6, pages 842-849.
Crossref
Crossref
Olena Sivak, Karen Bartlett, Verica Risovic, Eugene Choo, Fawziah Marra, D. Scotty BattyJr.Jr. & Kishor M. Wasan. (2004) Assessing the antifungal activity and toxicity profile of amphotericin B lipid complex (ABLC; Abelcet®) in combination with caspofungin in experimental systemic aspergillosis. Journal of Pharmaceutical Sciences 93:6, pages 1382-1389.
Crossref
Crossref
Rachel Courtney, Elaine Radwanski, Josephine Lim & Mark Laughlin. (2004) Pharmacokinetics of Posaconazole Coadministered with Antacid in Fasting or Nonfasting Healthy Men. Antimicrobial Agents and Chemotherapy 48:3, pages 804-808.
Crossref
Crossref
Harold W. Horowitz & Gary P. Wormser. 2004. AIDS and Other Manifestations of HIV Infection. AIDS and Other Manifestations of HIV Infection
305
370
.
Eleftherios Mylonakis, Frederick M. Ausubel, John R. Perfect, Joseph Heitman & Stephen B. Calderwood. (2002)
Killing of
Caenorhabditis
elegans
by
Cryptococcus neoformans
as a model of yeast pathogenesis
. Proceedings of the National Academy of Sciences 99:24, pages 15675-15680.
Crossref
Crossref